{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:55:34Z","timestamp":1767142534206,"version":"build-2238731810"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T00:00:00Z","timestamp":1699660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T00:00:00Z","timestamp":1699660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Folia Microbiol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s12223-023-01104-5","type":"journal-article","created":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T02:02:23Z","timestamp":1699668143000},"page":"999-1004","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Synergistic effect of the verapamil and amphotericin B against Cryptococcus neoformans"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7206-3348","authenticated-orcid":false,"given":"Tha\u00eds C.","family":"Pereira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3186-885X","authenticated-orcid":false,"given":"Paulo H. F.","family":"do Carmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4250-5528","authenticated-orcid":false,"given":"Raquel T.","family":"de Menezes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5760-4209","authenticated-orcid":false,"given":"Haroldo C.","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9956-7768","authenticated-orcid":false,"given":"Luciane D.","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6646-6856","authenticated-orcid":false,"given":"Juliana C.","family":"Junqueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0178-6653","authenticated-orcid":false,"given":"Liliana","family":"Scorzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,11]]},"reference":[{"key":"1104_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jgar.2018.04.004","volume":"14","author":"LM Alnajjar","year":"2018","unstructured":"Alnajjar LM, Bulatova NR, Darwish RM (2018) Evaluation of four calcium channel blockers as fluconazole resistance inhibitors in Candida glabrata. J Glob Antimicrob Resist 14:185\u2013189. https:\/\/doi.org\/10.1016\/j.jgar.2018.04.004","journal-title":"J Glob Antimicrob Resist"},{"key":"1104_CR2","unstructured":"Arendrup MC, Meletiadis J, Mouton JW et al (2017) EUCAST DEFINITIVE DOCUMENT E.DEF 7.3.1. Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts. 1\u201321"},{"key":"1104_CR3","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1093\/jac\/dku554","volume":"70","author":"LR Basso","year":"2015","unstructured":"Basso LR, Gast CE, Bruzual I, Wong B (2015) Identification and properties of plasma membrane azole efflux pumps from the pathogenic fungi Cryptococcus gattii and Cryptococcus neoformans. J Antimicrob Chemother 70:1396\u20131407. https:\/\/doi.org\/10.1093\/jac\/dku554","journal-title":"J Antimicrob Chemother"},{"key":"1104_CR4","doi-asserted-by":"publisher","unstructured":"Campitelli M, Zeineddine N, Samaha G, Maslak S (2017) Combination antifungal therapy: a review of current data. J Clin Med Res 9:451\u2013456. https:\/\/doi.org\/10.14740\/jocmr2992w","DOI":"10.14740\/jocmr2992w"},{"key":"1104_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2020.140135","volume":"740","author":"HCS Carneiro","year":"2020","unstructured":"Carneiro HCS, Bastos RW, Ribeiro NQ et al (2020) Hypervirulence and cross-resistance to a clinical antifungal are induced by an environmental fungicide in Cryptococcus gattii. Sci Total Environ 740:140135. https:\/\/doi.org\/10.1016\/j.scitotenv.2020.140135","journal-title":"Sci Total Environ"},{"key":"1104_CR6","doi-asserted-by":"publisher","unstructured":"Casadevall A, Mukherjee J, Scharff MD (1992) Monoclonal antibody based ELISAs for cryptococcal polysaccharide. J Immunol Methods 154:27\u201335. https:\/\/doi.org\/10.1016\/0022-1759(92)90209-C","DOI":"10.1016\/0022-1759(92)90209-C"},{"key":"1104_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1128\/EC.00331-08","volume":"8","author":"M De Jesus","year":"2009","unstructured":"De Jesus M, Nicola AM, Rodrigues ML et al (2009) Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan. Eukaryot Cell 8:96\u2013103. https:\/\/doi.org\/10.1128\/EC.00331-08","journal-title":"Eukaryot Cell"},{"key":"1104_CR8","doi-asserted-by":"publisher","unstructured":"de Oliveira HC, Joffe LS, Simon KS et al (2020) Fenbendazole controls in vitro growth, virulence potential, and animal infection in the Cryptococcus model. Antimicrob Agents Chemother 64. https:\/\/doi.org\/10.1128\/AAC.00286-20","DOI":"10.1128\/AAC.00286-20"},{"key":"1104_CR9","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1093\/jac\/dkt114","volume":"68","author":"GF Ferreira","year":"2013","unstructured":"Ferreira GF, de Baltazar L, M, Santos JRA et al (2013) The role of oxidative and nitrosative bursts caused by azoles and amphotericin B against the fungal pathogen Cryptococcus gattii. J Antimicrob Chemother 68:1801\u20131811","journal-title":"J Antimicrob Chemother"},{"key":"1104_CR10","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s15010-018-1152-2","volume":"46","author":"K G\u00f3ralska","year":"2018","unstructured":"G\u00f3ralska K, Blaszkowska J, Dzikowiec M (2018) Neuroinfections caused by fungi. Infection 46:443\u2013459. https:\/\/doi.org\/10.1007\/s15010-018-1152-2","journal-title":"Infection"},{"key":"1104_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2021.100745","volume":"22","author":"L Gouveia-Eufrasio","year":"2021","unstructured":"Gouveia-Eufrasio L, Ribeiro NQ, Santos JRA et al (2021) Randomized, phase 1\/2, double-blind pioglitazone repositioning trial combined with antifungals for the treatment of cryptococcal meningitis - PIO study. Contemp Clin Trials Commun 22:100745. https:\/\/doi.org\/10.1016\/j.conctc.2021.100745","journal-title":"Contemp Clin Trials Commun"},{"key":"1104_CR12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1089\/adt.2016.714","volume":"14","author":"P Gupta","year":"2016","unstructured":"Gupta P, Chanda R, Rai N et al (2016) Antihypertensive, amlodipine besilate inhibits growth and biofilm of human fungal pathogen Candida. Assay Drug Dev Technol 14:291\u2013297. https:\/\/doi.org\/10.1089\/adt.2016.714","journal-title":"Assay Drug Dev Technol"},{"key":"1104_CR13","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3389\/fmicb.2017.00535","volume":"8","author":"LS Joffe","year":"2017","unstructured":"Joffe LS, Schneider R, Lopes W et al (2017) The anti-helminthic compound mebendazole has multiple antifungal effects against Cryptococcus neoformans. Front Microbiol 8:535. https:\/\/doi.org\/10.3389\/fmicb.2017.00535","journal-title":"Front Microbiol"},{"key":"1104_CR14","first-page":"817","volume":"262","author":"NM Kaplan","year":"1989","unstructured":"Kaplan NM (1989) Calcium entry blockers in the treatment of hypertension. Current Status and Future Prospects JAMA 262:817\u2013823","journal-title":"Current Status and Future Prospects JAMA"},{"key":"1104_CR15","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.ijantimicag.2013.12.009","volume":"43","author":"S Liu","year":"2014","unstructured":"Liu S, Hou Y, Chen X et al (2014) Combination of fluconazole with non-antifungal agents: a promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery. Int J Antimicrob Agents 43:395\u2013402. https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.12.009","journal-title":"Int J Antimicrob Agents"},{"key":"1104_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150859","volume":"11","author":"S Liu","year":"2016","unstructured":"Liu S, Yue L, Gu W et al (2016) Synergistic effect of fluconazole and calcium channel blockers against resistant Candida albicans. PLoS ONE 11:e0150859. https:\/\/doi.org\/10.1371\/journal.pone.0150859","journal-title":"PLoS ONE"},{"key":"1104_CR17","doi-asserted-by":"publisher","unstructured":"Mourad A, Perfect JR (2018) Present and future therapy of Cryptococcus infections. J Fungi 4. https:\/\/doi.org\/10.3390\/jof4030079","DOI":"10.3390\/jof4030079"},{"key":"1104_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3390\/jof3030050","volume":"3","author":"H Nazik","year":"2017","unstructured":"Nazik H, Choudhary V, Stevens D (2017a) Verapamil inhibits Aspergillus biofilm, but antagonizes voriconazole. J Fungi 3:50. https:\/\/doi.org\/10.3390\/jof3030050","journal-title":"J Fungi"},{"key":"1104_CR19","doi-asserted-by":"publisher","unstructured":"Nazik H, Choudhary V, Stevens DA (2017b) Verapamil inhibits Aspergillus biofilm, but antagonizes voriconazole. J Fungi 3. https:\/\/doi.org\/10.3390\/jof3030050","DOI":"10.3390\/jof3030050"},{"key":"1104_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkg301","volume":"52","author":"FC Odds","year":"2003","unstructured":"Odds FC (2003) Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 52:1","journal-title":"J Antimicrob Chemother"},{"key":"1104_CR21","doi-asserted-by":"publisher","unstructured":"Pereira TC, de Menezes RT, de Oliveira HC et al (2021) In vitro synergistic effects of fluoxetine and paroxetine in combination with\u00a0amphotericin B against Cryptococcus neoformans. Pathog Dis 79. https:\/\/doi.org\/10.1093\/femspd\/ftab001","DOI":"10.1093\/femspd\/ftab001"},{"key":"1104_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA et al (2019) Drug repurposing: progress, challenges and recommendations. Nat Re Drug Discov 18:41\u201358. https:\/\/doi.org\/10.1038\/nrd.2018.168","journal-title":"Nat Re Drug Discov"},{"key":"1104_CR23","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","volume":"17","author":"R Rajasingham","year":"2017","unstructured":"Rajasingham R, Smith RM, Park BJ et al (2017) Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis 17:873\u2013881. https:\/\/doi.org\/10.1016\/S1473-3099(17)30243-8","journal-title":"Lancet Infect Dis"},{"key":"1104_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s002849910030","volume":"40","author":"AAG Rodrigues","year":"2000","unstructured":"Rodrigues AAG, Pina-Vaz C, M\u00e5rdh P-A et al (2000) Inhibition of germ tube formation by Candida albicans by local anesthetics: an effect related to ionic channel blockade. Curr Microbiol 40:145\u2013148. https:\/\/doi.org\/10.1007\/s002849910030","journal-title":"Curr Microbiol"},{"key":"1104_CR25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s12223-016-0449-8","volume":"61","author":"L Rossato","year":"2016","unstructured":"Rossato L, Loreto \u00c9S, Zanette RA et al (2016) In vitro synergistic effects of chlorpromazine and sertraline in combination with amphotericin B against Cryptococcus neoformans var. grubii. Folia Microbiol 61:399\u2013403. https:\/\/doi.org\/10.1007\/s12223-016-0449-8","journal-title":"Folia Microbiol"},{"key":"1104_CR26","doi-asserted-by":"publisher","unstructured":"Rueden CT, Hiner MC, Eliceiri KW (2016) ImageJ: image analysis interoperability for the next generation of biological image data. Microsc Microanal 22:2066\u20132067. https:\/\/doi.org\/10.1017\/S143192761601117X","DOI":"10.1017\/S143192761601117X"},{"key":"1104_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fmicb.2017.00036","volume":"8","author":"L Scorzoni","year":"2017","unstructured":"Scorzoni L, de Paula E, Silva ACA, Marcos CM et al (2017) Antifungal therapy: new advances in the understanding and treatment of mycosis. Front Microbiol 8:36. https:\/\/doi.org\/10.3389\/fmicb.2017.00036","journal-title":"Front Microbiol"},{"key":"1104_CR28","doi-asserted-by":"publisher","DOI":"10.1590\/0001-3765202020200703","volume":"92","author":"L Scorzoni","year":"2020","unstructured":"Scorzoni L, Menezes RTDE, Pereira TC et al (2020) Antifungal and anti-biofilm effect of the calcium channel blocker verapamil on non-albicans Candida species. An Acad Bras Cienc 92:e20200703. https:\/\/doi.org\/10.1590\/0001-3765202020200703","journal-title":"An Acad Bras Cienc"},{"key":"1104_CR29","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1128\/AAC.01087-13","volume":"58","author":"M Stylianou","year":"2014","unstructured":"Stylianou M, Kulesskiy E, Lopes JP et al (2014) Antifungal application of nonantifungal drugs. Antimicrob Agents Chemother 58:1055\u20131062. https:\/\/doi.org\/10.1128\/AAC.01087-13","journal-title":"Antimicrob Agents Chemother"},{"key":"1104_CR30","doi-asserted-by":"publisher","unstructured":"Winski CJ, Qian Y, Mobashery S, Santiago-Tirado FH (2022) An atypical ABC transporter is involved in antifungal resistance and host interactions in the pathogenic fungus Cryptococcus neoformans. mBio 13. https:\/\/doi.org\/10.1128\/mbio.01539-22","DOI":"10.1128\/mbio.01539-22"},{"key":"1104_CR31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2174\/1874467210801020093","volume":"1","author":"C-P Wu","year":"2008","unstructured":"Wu C-P, Calcagno A, Ambudkar S (2008) Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies. Curr Mol Pharmacol 1:93\u2013105. https:\/\/doi.org\/10.2174\/1874467210801020093","journal-title":"Curr Mol Pharmacol"},{"key":"1104_CR32","doi-asserted-by":"publisher","unstructured":"Yu Q, Ding X, Xu N et al (2013) In vitro activity of verapamil alone and in combination with fluconazole or tunicamycin against Candida albicans biofilms. Int J Antimicrob Agents 41:179\u2013182. https:\/\/doi.org\/10.1016\/j.ijantimicag.2012.10.009","DOI":"10.1016\/j.ijantimicag.2012.10.009"},{"key":"1104_CR33","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.mib.2019.11.001","volume":"52","author":"H Zafar","year":"2019","unstructured":"Zafar H, Altamirano S, Ballou ER, Nielsen K (2019) A titanic drug resistance threat in Cryptococcus neoformans. Curr Opin Microbiol 52:158\u2013164. https:\/\/doi.org\/10.1016\/j.mib.2019.11.001","journal-title":"Curr Opin Microbiol"},{"key":"1104_CR34","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1080\/21505594.2019.1614383","volume":"10","author":"O Zaragoza","year":"2019","unstructured":"Zaragoza O (2019) Basic principles of the virulence of Cryptococcus. Virulence 10:490\u2013501. https:\/\/doi.org\/10.1080\/21505594.2019.1614383","journal-title":"Virulence"},{"key":"1104_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1251\/bpo68","volume":"6","author":"O Zaragoza","year":"2004","unstructured":"Zaragoza O, Casadevall A (2004) Experimental modulation of capsule size in Cryptococcus neoformans. Biol Proced Online 6:10\u201315. https:\/\/doi.org\/10.1251\/bpo68","journal-title":"Biol Proced Online"},{"key":"1104_CR36","doi-asserted-by":"publisher","unstructured":"Zaragoza O, Rodrigues ML, De Jesus M et al (2009) Chapter 4 The capsule of the fungal pathogen Cryptococcus neoformans. In Laskin A. Sariaslani\u00a0S, Gadd G (Eds.) Adv Appl Microbiol (pp. 133\u2013216). Adv Appl Microbiol 68. https:\/\/doi.org\/10.1016\/S0065-2164(09)01204-0","DOI":"10.1016\/S0065-2164(09)01204-0"},{"key":"1104_CR37","doi-asserted-by":"publisher","unstructured":"Zeng Q, Zhang Z, Chen P et al (2019) In vitro and in vivo efficacy of a synergistic combination of itraconazole and verapamil against Aspergillus fumigatus. Front Microbiol 10. https:\/\/doi.org\/10.3389\/fmicb.2019.01266","DOI":"10.3389\/fmicb.2019.01266"}],"updated-by":[{"DOI":"10.1007\/s12223-023-01127-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000}}],"container-title":["Folia Microbiologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-023-01104-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12223-023-01104-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-023-01104-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T06:57:28Z","timestamp":1724396248000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12223-023-01104-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,11]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1104"],"URL":"https:\/\/doi.org\/10.1007\/s12223-023-01104-5","relation":{},"ISSN":["0015-5632","1874-9356"],"issn-type":[{"value":"0015-5632","type":"print"},{"value":"1874-9356","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,11]]},"assertion":[{"value":"13 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12223-023-01127-y","URL":"https:\/\/doi.org\/10.1007\/s12223-023-01127-y","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}